Stock SYRE SPYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Real-time Estimate Cboe BZX
Other stock markets
 15:27:08 15/05/2024 BST 		5-day change 1st Jan Change
38.05 USD -3.16% Intraday chart for Spyre Therapeutics, Inc. +20.31% +84.60%
05-13 Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating MT
05-09 Spyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
f3d6b3c.Rk2Im-zd3ha0nk93RqrjSVotNDiofl3sxMDSW8uvhOM.CxTyrtiRm3va2TZHc92IfyJCQluRGBypqfC9PoHwvakKCrHMwZS5TuTtCg~cac35fc47da3c3d3056b0c8b8ce626ea
  1. Stock Market
  2. Equities
  3. SYRE Stock
  4. Charts Spyre Therapeutics, Inc.
  5. News Chart